Healthcare Strategy & Consulting

At Medicys, we partner with leading global strategy and consulting firms who advise healthcare business leaders on their most critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers & acquisitions. Typical projects in this space will focus on:

Market Sizing & Value Proposition development
Digital Marketing & Sales Strategy
End-to-End Patient Experience Strategy
Asset identification and acquisition
Telehealth implementation
Portfolio management and prioritisation
Patient Support Program (PSP) strategy
Strategic positioning
Competitive analysis

In practice, we do this through providing primary research services to provide the market understanding and evidence needed to support the analysis and strategic recommendations of the consulting team.

We can connect healthcare consultants with the respondents they need, be they health care professionals, KOLs and/or local, regional or national level payers, patients, patient organisations or other relevant targets to inform their strategy planning.

The properly sourced and well vetted research participants we can access are key to produce actionable insight.

Related Work

See all Work

healthcare strategy and consulting

Therapy Area: Lysosomal storage Disorders

Topic: Pompe Disease

Respondent Type: Treaters of Pompe Disease

To explore and understand the treatment practice for patients with Pompe disease

Countries:

Sample Size: 8

Methodology: 60 minute Web Assisted Telephone Depth Interviews (WATDIs)

Services Delivered: Recruitment

healthcare strategy and consulting

Therapy Area: Lab Science

Topic: Biobanks

Respondent Type: Administrators

Understand biobank capabilities, areas of expertise and opportunities for scientific collaboration

Countries:

Sample Size: 24

Methodology: 90 minute Web Assisted Telephone Depth Interviews (WATDIs)

Services Delivered: Moderation and transcripts

healthcare strategy and consulting

Therapy Area: Haematology

Topic: CAR-T cell treatments and bispecific antibody treatments for multiple myeloma

Respondent Type: Haematologists

To better understand perspectives on the type of logistical and practical issues HCPs encounter when considering patients for treatment with CAR-T and bispecifics and how do these might impact treatment decisions.

Countries: